Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • Fourfront Limited Files DRHP On BSE SME For IPO Business
  • Tap Into India’s Urban Growth Story with CEPT’s Specialised MBA Programs Education
  • Mega Flex Plastics Ltd’s Rs. 11.40 crore public issue on NSE EMERGE platform opens for subscription on 6th September Business
  • Functional & Innovative Foods Limited Filed DRHP With SEBI Business
  • Globe Civil Projects Limited Secures Rs 98.85 Crore Residential Project at IIT Delhi Extension Campus Business
  • SOUHARDYA 2026 Inaugurated at RGIPT Jais, Promoting Social Innovation, Sustainability and Entrepreneurship National
  • Unlocking the Power of Education: Bridging the Employability Gap Education
  • ACL Chronicles: From Diagnosis to Rehabilitation – A Holistic Approach Health

Lincoln Pharmaceuticals Ltd enters elite league; Enters Rs. 1,000 crore plus market cap club

Posted on August 30, 2023 By

Company has set a target of achieving Rs. 750 crore revenue by FY26

Ahmedabad (Gujarat) [India], August 30: Lincoln Pharmaceuticals Limited, one of India’s leading healthcare companies has entered the elite league and Rs. 1,000 crore plus market capitalization companies club for the first time. Share price of the company hit a 52 week high of Rs. 513 per share on 28 August 2023 – gain of over 75% in a year’s time. Company aims to maintain healthy growth in revenue and margins in the coming years and has set a target of achieving Rs. 750 crore revenue by FY26 while maintaining its ‘Net Debt Free’ status.

For FY23, the company has reported its Best-ever results in a financial year with highest – Revenue, EBITDA and Net Profit. Company achieved a milestone of Rs. 500 crore plus revenue and Rs. 100 crore plus profit before tax for the first time in a financial year. During Q1FY24 also, company reported an excellent operational and financial performance with Y-o-Y growth of 26.7% in Net Profit, 21.4% growth in EBITDA and 10.3% growth in Total Income.

Company has successfully completed expansion of the Cephalosporin plant at Mehsana, Gujarat. Commercial production from this plant has started and the company started selling in the domestic markets with product registration under process for many countries for exports. The plant is expected to contribute sales of around Rs. 150 crore in next 3 years.

Company is also ranked among a very few companies to achieve a profit growth every single year from FY13 to FY23. It is among only 16 companies out of 4,200 plus listed companies in the Indian stock exchange to do so as per the analysis of Morningstar. During 10 years from FY13 to FY23, Company has delivered a robust CAGR of over 22% in Net profits, 19% plus in EBITDA and over 10% in Revenue.

Financial Performance – Lincoln Pharmaceuticals FY 13 to FY23

Rating agencies, CRISIL has upgraded its ratings on the company’s bank facilities to ‘CRISIL A/Stable and CRISIL A1’. ICRA too has reaffirmed the company’s long-term and short-term bank facilities to A and A1 respectively. The liquidity position of the company is on a strong foundation, supported by healthy cash accruals, no-term debt, and healthy return ratios.

Over the last few years, promoter group have gradually increased their stake in the company. Foreign institutional investors holding as on June 2023 stands at 1.74%. In the last one year, share price of the company has gained by over 75% – from Rs. 283.5 per share on 29 August 2022 to Rs. 4505 per share at close on 28 August 2023.

Company currently exports to 60 plus countries including East & West Africa, Central, North & Latin America and Southeast Asia. Company has recently started exports to Canada. TGA – Australia and EU GMP approvals will further strengthen the company’s presence and expand its network to 90 plus countries.

Lincoln Pharma has a state-of-the-art manufacturing facility unit at Khatraj in Ahmedabad, Gujarat, complying with stringent international quality and compliance norms and certified by EUGMP, TGA, WHO-GMP; ISO-9001:2015, ISO-14001:2015 and ISO-45001:2018. Company has developed 600 plus formulations in 15 therapeutic areas and has a strong product/brand portfolio in anti-infective, respiratory system, gynaecology, cardio & CNS, anti-bacterial, ant-diabetic, anti-malaria among others. Company has filed 25 plus patent applications and is awarded with seven patents.

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

Business Tags:Business

Post navigation

Previous Post: Funding Guru Subodh Bajpai Launches his Book Rise and Thrive Unleashing The Entrepreneurial Warrior”
Next Post: CSR Times and Indian Achievers’ Forum host the National Seminar on “Achieving SDG’s through CSR in developing Economies: Role of G20 Nations”

Related Posts

  • Infinite Health Studios Collaborated With Top Laboratories and Hospitals to Provide Customized Healthcare Programs & Wellness Solutions Pan India Business
  • Indipaisa, awarded India’s fastest-growing brand starts empowering MSMEs Business
  • Art 4 Peace Awards Hosts a Remarkable Event Recognizing Global Peace Efforts -World News Network Business
  • Drewknot Footwear: 7 Bold Moves Redefining Affordable Premium Fashion Business
  • Captain Polyplast Limited Reports Robust Q2 & H1 FY27 Growth, with Total Income Rising 32.89% & 25.14%, Respectively Business
  • Toyota unveils 5th generation self-charging Innova HyCross in Ahmedabad Business

Recent Posts

  • Building ISAK Fragrances: From a 170 Year Family Legacy to a Modern Luxury Brand
  • From the Mountains to the Sea: Captain Sanjay’s Initiative Opens New Career Opportunities for Himachal’s Daughters in the Merchant Navy
  • Shanti Educational Initiatives Wins BSE Clearance for Merger With Solar Powerhouse GREW Energy
  • How IH Global Helps Businesses Build Powerful Brand Experiences Through Exhibition Design, Trade Shows and Experiential Technology
  • How to Choose Furniture That Complements Your Lifestyle and Living Space

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Excitement Builds as ASTCL Inaugural Season Draft Day Takes Place Sports
  • Northeast India’s Medical Education Boom Positions Tripura as an Emerging Destination for Aspiring Doctors Education
  • Maneesh Pandey: The Lending Leader Empowering Homebuyers, Entrepreneurs and India’s Real Estate Growth Lifestyle
  • Varaha Heritage Bringing Technology and Culture Together for a Richer Public Experience Technology
  • Banke Eyes Rs 1,000 Crore Milestone After Strong Rs 587 Crore Performance in Mumbai Business
  • Storydek, India’s first family-friendly OTT platform, launched by Anand & Pallavi Gupta Business
  • Aayush Wellness Limited Expands into Preventive Healthcare with Smart Kiosks & Medical Support Center Business
  • Darkweb And Cybercrime Monitoring Startup Cyble Announces US $10 Million in Series A Funding Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme